BlackRock Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
NCGI
GIM
CRC
DCM
BFA
BIT
BlackRock Investment Management's NEO Position: Q4 2016 in Review
BlackRock Investment Management reduced its NeoGenomics (NEO) stake by 0.31% in Q4 2016, selling an estimated $5.6K and leaving 207,075 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2297.
BlackRock Investment Management first reported a position in NEO in Q2 2013 and has held it in 15 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.
- BlackRock Investment Management held 207,075 shares of NeoGenomics worth $1.77M as of Q4 2016.
- BlackRock Investment Management sold 654 NeoGenomics shares in Q4 2016, an estimated $5.6K.
- NeoGenomics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2297 holding.
- BlackRock Investment Management first reported a position in NeoGenomics in Q2 2013 and has held it in 15 quarters since.
- 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.